Trial and Error: How to Avoid Commonly Encountered Limitations of Published Clinical Trials
- 2 February 2010
- journal article
- review article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 55 (5), 415-427
- https://doi.org/10.1016/j.jacc.2009.06.065
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- The Value of p-Value in Biomedical ResearchThe Open Cardiovascular Medicine Journal, 2008
- Prior convictions: bayesian approaches to the analysis and interpretation of clinical megatrialsJournal of the American College of Cardiology, 2004
- ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina)Journal of the American College of Cardiology, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor TirofibanThe New England Journal of Medicine, 2001
- Sifting the evidence---what's wrong with significance tests? Another comment on the role of statistical methodsBMJ, 2001
- Toward Evidence-Based Medical Statistics. 1: The P Value FallacyAnnals of Internal Medicine, 1999
- Clinical significance not statistical significance: a simple Bayesian alternative to p valuesJournal of Epidemiology and Community Health, 1998
- Placing Trials in Context Using Bayesian AnalysisJAMA, 1995
- The number needed to treat: a clinically useful measure of treatment effectBMJ, 1995